FDA Investigator Liatte Kreuger, PharmD

Liatte Kreuger, PharmD has inspections in 8 countries as of 14 Sep 2023. Liatte Kreuger, PharmD has collaborated with a combinined 5010 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:

Last Inspection Date:

14 Sep 2023

Investigator Role:

FDA Investigation Participant

Redica ID:

100000398

Country:

United States of America, Romania, Switzerland, Israel, Germany, Canada, Hungary, Finland

Co-Investigator(s):

Addam S Reynolds, Adetutu M Gidado, Alan L Truong, Alberto A Viciedo, Allen F Hall, Allen Lou, Amatul H Marium, Amy L Singer, Amy M Cramer, Ana S Cabrera, Ankur C Patel, Ann Marie Montemurro, Anna Lazar, Annemarie B Randow, Annemarie Bodnar, Anthony J Donato, Anthony M Criscuolo, Jr, Atul J Agrawal, Azza Talaat, Barbara J Maulfair, Barbara J Wilimczyk, Barbara Jwilimczyk Macri, Barbara L Rellahan, PhD, Barry Rothman, Binh T Nguyen, Brooke K Higgins, Byungja E Marciante, Cara M Minelli, Cary Greene, Caryn M Mcnab, CDR Ileana Barreto Pettit, Charisse K Green, Charles J Chacko, Charles L Zhou, Charles M Edwards, Charles R Cote, RIC, Cheryl A Grandinetti, Cheryl Llove Harris, Christina N Maurino, Christine M Cerenzio, Christine W Twohy, Claire M Minden, Craig W Swanson, Daniel J Grabicki, Daniel J Roberts, Daniel W Cline, Daryl A Dewoskin, David H Smith, David M Beltran, Dawn L Wydner, Deborah B Nixon, Debra I Love, Delaram Moshkelani, Denise M Visco, Investigator, Dennis Cantellops Paite, Devon Jenkins, Dhaval H Patel, Diane B Radice, Dorothy J Denes, Douglas C Kovacs, Dr. Robert C Horan, MD, Dr. Zhou Chen (nmi), MD PhD, Edward P Potter, Emest F Bizjak, Emily A Walters, Emmanuel J Ramos, Eric J Cunningham, Eric L Dong, BS, Eric Rothschild, Erin D Mccaffery, Erin Rothschild, Esteban Beltran, Felix Maldonado, Frank J Marciniak, Frederick Razzaghi, Gabriel Feng, Gajendiran Mahadevan, PhD, Gale L Glinecki, Gam S Zamil, George Pyramides, Gianine E Delade, Gianine E Tompkins, Guerlain Ulysse, Gwyn G Dickinson, Haitao Li, Hamet M Toure, PharmD MPH, Helen B Ricalde, Helen Verdel, Heriberto Negron Rivera, Himanshu Gupta, PhD, Holly S Simms, Jacqueline Mdiaz Albertini, James L Dunnie, Jr, James R Birkenstamm, James W Leonette, Jananiga Vanniyasingam, Jawaid Hamid, Jean Blackston Hill, Jean Blackstone Hill, Jean M Kelahan, Jeffrey A Sommers, Jessica S Estriplet, Joan A Loreng, Joel D Hustedt, Jogy George, Jonathan W Chapman, Jonee J Mearns, Jorge L Gonzalez, Jose A Lopez, Jose Alopez Rubet, Jose M Cayuela, Joseph F Mcginnis, RPh, Joseph Mcginnis, Joshua P Wireman, Joy Rkozlowski Klena, Justine Tomasso, Karen A Briggs, Karen E D'orazio, Kassa Ayalew, MD, Katherine Szestypalow, Kathryn E Ogger, Keith M Reilly, Kelli F Dobilas, Kelli Regente, Kellia N Hicks, Kelly Doremus, Kenneth M Gordon, Kerry A Kurdilla, Kevin Obrien, Kim Lthomas Cruse, Kimberley A Hoefen, King, Kinh Q Mac, Ko U Min, Krishnaiah Yellela, Kristina L Conroy, Kristy A Zielny, Krystal O Ogunremi, L Izaam Lam, Laishan L Lam, Lata C Mathew, PhD, Lauren L Vajo, Lawrence R Johnson, Leonard H Lavi, Li Li, Liattle Krueger, Libia M Lugo, Lisa Harlan, Lisa M Bellows, Lisa M Feola, Luella J Rossi, Luis A Dasta, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Margaret E Walsh, Margaret M Annes, Maria A Bienkowski, Maria A Reed, Maria Estrella, Maria Manzoni, PhD, Marianela Aponte Cruz, Marie Bbuen Bigornia, Marjorie D Schultz, Marybet Lopez, Matthew A Spataro, Matthew B Casale, Mayar M Mussa, Melba T Rivera, Melba Trivera Clavell, Melissa A Freeman, Melissa B Libby, Melissa D Ray, Melissa J Garcia, Melissa T Roy, Meredith L Sheridan, Michael E Maselli, Michael R Klapal, Michael Serrano, Michele Gottshall, Miguel G Manzano, Mihaly S Ligmond, Mindy M Chou, Monika Borkowska, Mra M Barbosar, Mra Mcculloughj, Nadeem I Chaudhry, Namita Kothary, Nancy F Scheraga, Nancy L Rolli, Nancy M Espinal, Natasha Gupta, Nebil A Oumer, Nerizza B Guerin, Nicholas A Violand, Nicholas L Paulin, Niketa Patel, Nikki S Ramirez, Nina Yang, Niraj Mehta, Nyungja E Marciente, Omotunde O Osunsanmi, Parul M Patel, Patsy J Domingo, Paul L Bellamy, Paula J Bretz, Peter C Chow, Peter R Lenahan, Prabhu P Raju, Rachael A Moliver, Rachel C Harrington, Rebecca E Dombrowski, Rebecca Rodriguez, Regina T Brown, Remache, Richard D Manney, Richard J Muzeni, Robert D Tollefsen, Robert W Jennings, Robin P Mathew, Rochelle K Kimmel, Rochelle L Cross, Rodney G Raiford, Rodney T Allnutt, Roger F Zabinski, Rose Ljean Mary, Russell J Glapion, Russell K Riley, Sachinkumar V Patel, Saleem A Akhtar, Sandra A Hughes, Sandra Kershaw, Sarah Adella Fave, Sarah E Mcmullen, Sarah Forney, Schultz, Scott J Lewis, Sena G Dissmeyer, Shahla Parvizi, Sharon K Thoma, PharmD, Sherri J Liu, Shirley H Isbill, Sidney B Priesmeyer, Sinai Davis, State Agency, Stephanie T Durso, Stephen J Mottola, Steven A Gonzales, Steven D Kehoe, Sue Lee Chan, Sunita Iyer, Susan M Halsted, Susan M Joseph, Susant Hadman, Suzanne M Healy, Suzanne M Muchene, Taichun Qin, PhD, Tamil Arasu, PhD, Tania E Vizcaino, Tara G Bizjak, Tara R Gooen, Terri L Dodds, Thomas J Arista, Thomas M Herbst, Thomas S Arista, Tiffani D Wilson, Tonia F Bernard, Tracey L Harris, Tressa T Lewis, Truong Xuan Nguyen (Andy), Tyanna N Hadley, Tynna N Hadley, Unnee Ranjan, Valerie C Reed, Valerie Reed, Victoria Spivak, Vilmary Negron Rodriguez, Virgilio F Pacio, CSO, Walden H Lee, Wayne J Meyer, Wendy G Tan, PhD, Xiaohan Cai, PhD, Yumi J Hiramine, Yvesna C Blaise, Yvins Dezan, Zakaria I Ganiyu

Liatte Kreuger, PharmD's Documents

Publish Date	Document Type	Title
July, 2012	EIR	DAVA Pharmaceuticals, Inc. - EIR, 2012-07-06
January, 2012	EIR	Actavis Elizabeth LLC - EIR, 2012-01-13
April, 2011	FDA 483	Actavis Elizabeth LLC - Form 483, 2011-04-26
June, 2010	EIR	Triarco Industries, Inc. - EIR, 2010-06-02
December, 2014	EIR	Xellia Pharmaceuticals Ltd. - EIR, 2014-12-05
May, 2014	FDA 483	Akorn Operating Company LLC (dba Akorn) - Form 483, 2014-05-29
February, 2016	FDA 483 Response	Elite Laboratories, Inc. - Form 483R, 2016-08-16
April, 2011	EIR	Actavis Elizabeth LLC - EIR, 2011-04-26
May, 2012	FDA 483	Givaudan Flavors Corporation - Form 483, 2012-05-17
March, 2015	EIR	Micra Biotechnologies Inc - EIR, 2015-03-10
April, 2016	FDA 483	Assia Chemical Industries Ltd. - Teva Tech Site - Form 483, 2016-04-14
November, 2012	FDA 483	Orion Corporation - Form 483, 2012-11-02
August, 2013	EIR	Vitaquest International LLC d/b/a State Nutritionals, Inc. - EIR, 2013-08-28
March, 2013	FDA 483	Dimensional Merchandising Inc. - Form 483, 2013-03-15
March, 2015	FDA 483	Micra Biotechnologies Inc - Form 483, 2015-03-10
January, 2014	FDA 483	SGS North America Inc. - Form 483, 2014-01-21
January, 2013	FDA 483	Eisai Inc - Form 483, 2013-01-17
February, 2011	FDA 483	Hoffmann La Roche Inc - Form 483, 2011-02-04
April, 2016	FDA 483	Vetter Pharma Fertigung GmbH & Co. KG (Langenargen Eisenbahnstrasse) - Form 483, 2016-04-26
July, 2015	FDA 483	Sun Pharmaceutical Industries, Inc. - Form 483, 2015-07-15
December, 2013	FDA 483	J. Knipper and Company, Inc. - Form 483, 2013-12-17
February, 2010	FDA 483	Scientech Laboratories, Inc. - Form 483, 2010-02-25
July, 2012	FDA 483	DAVA Pharmaceuticals, Inc. - Form 483, 2012-07-17
October, 2014	FDA 483	ACUPAC PACKAGING INC - Form 483, 2014-10-27
October, 2010	FDA 483	Sani-pure Food Laboratories Llc - Form 483, 2010-10-20
March, 2015	FDA 483 Response	Micra Biotechnologies Inc - Form 483R, 2015-03-10
April, 2011	FDA 483 Response	Actavis Elizabeth LLC - Form 483R, 2011-06-15
September, 2014	FDA 483	Amarin Pharma Inc. - Form 483, 2014-09-09
January, 2012	FDA 483	Actavis Elizabeth LLC - Form 483, 2012-01-13
March, 2016	FDA 483	Forest Research Institute, Inc. - Form 483, 2016-03-18
August, 2016	FDA 483	Town and Country Compounding and Consultation Services, LLC - Form 483, 2016-08-22
April, 2012	FDA 483	Contract Coating Inc. - Form 483, 2012-04-09
November, 2014	FDA 483	Brisar Industries, Inc. - Form 483, 2014-11-20
May, 2013	FDA 483	Excellentia International, LLC - Form 483, 2013-05-15
August, 2014	FDA 483	Konsyl Pharmaceuticals, Inc. - Form 483, 2014-08-01
July, 2015	FDA 483	Millers of Wyckoff, Inc. - Form 483, 2015-07-16
January, 2013	EIR	Eisai Inc - EIR, 2013-01-17
February, 2016	FDA 483	Elite Laboratories, Inc. - Form 483, 2016-02-02
October, 2016	FDA 483	PharmScript, LLC - Form 483, 2016-10-24
July, 2014	FDA 483	Alcami Corporation - Form 483, 2014-07-17
August, 2015	FDA 483	5N Plus Lübeck GmbH - Form 483, 2015-08-07
November, 2015	FDA 483	PETNET SOLUTIONS, INC. - Form 483, 2015-11-03

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more